ICO
Closed:

Genetic Therapy Solutions for Severe Neurological Disorders

Header

Neurogene is a global biotechnology company whose mission is to advance genetic medicines for the treatment of neurological disorders. Neurogene is interested in engaging with new academic partners focused on the use of genetic medicines to treat severe neurological disorders, including neurodevelopmental, neurodegenerative, and neuroinflammatory diseases as well as genetic epilepsies.

Our client wishes to engage with academic partners that utilize traditional gene replacement via a vectorized delivery as well as novel technological approaches for diseases...

Opportunity types being sought:

  • Technology

  • Academic Researcher

  • Centre of Excellence

  • Research Project

  • Spinout Company

To see the full details and submit your response please register now.

Benefits of registration:

  • Receive updates on the latest industry calls
  • Quickly and easily respond to calls via your dashboard
  • Build your academic profile
Powered ByInpart
An online matchmaking platform for university-industry collaboration. Learn More

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.